Effect of Electrical Muscle Stimulation in Critically Ill Patients
The Effects of Electrical Muscle Stimulation (EMS) on Muscle Atrophy and Functional Outcomes in Critically Ill Patients; a Pilot Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
Electrical muscle stimulation (EMS) is the therapy used to passively activate muscles using electrodes on the surface of the skin. EMS may be helpful in preserving muscle function in people who are on bedrest due to critical illness in the intensive care unit. The purpose of this study is to determine the safety and feasibility of implementing EMS in critically ill patients who are on mechanical ventilation for greater than 7 days, and examine the effects of 4 weeks of EMS on leg muscle size, muscle strength and functional outcomes in these patients. The investigators hypothesize that EMS will be safe and feasible and that critically ill patients receiving EMS will show a smaller loss of muscle size and strength than those in the control group, who do not receive EMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jul 2012
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 6, 2012
CompletedFirst Posted
Study publicly available on registry
July 11, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFebruary 9, 2016
May 1, 2015
3.3 years
July 6, 2012
February 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
feasibility of EMS treatment
the number of EMS treatments that are successfully applied will be expressed as a frequency of the total number of treatments attempted
4 weeks
Secondary Outcomes (2)
muscle strength
baseline, 2 weeks and 4 weeks
muscle thickness
baseline, 2 weeks, 4 weeks
Study Arms (2)
EMS intervention
EXPERIMENTALThe experimental group will received EMS at a therapeutic level.
Sham
SHAM COMPARATORThe sham group will receive EMS at a sub-therapeutic level.
Interventions
EMS delivered to the quadriceps and gluteal muscles, twice daily, 30 minutes per session for up to 4 weeks.
Sham EMS delivered to the quadriceps and gluteal muscles, twice daily, 30 minutes per session for up to 4 weeks.
Eligibility Criteria
You may qualify if:
- admitted to the medical-surgical ICU or cardiovascular ICU
- walking independently prior to admission
- mechanically ventilated for more than 7 days (i.e. prolonged ventilation)
- receiving enteral or parenteral nutrition.
You may not qualify if:
- history of neurological or psychiatric disease
- primary muscle disease (e.g. muscular dystrophy, polymyositis)
- catastrophic neurological event
- receiving palliative care
- contraindications to EMS (e.g. cardiac pacemaker/defibrillator, pregnancy, infected or cancerous lesions in proximity of electrode sites)
- inadequate access to electrode sites due to medical devices
- lower extremity edema affecting the thighs or buttocks
- BMI \> 35 kg/m2
- allergies to adhesives or latex
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- The Lung Associationcollaborator
Study Sites (1)
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vincent Lo, BSc(PT)
University Health Network, Toronto
- PRINCIPAL INVESTIGATOR
Sunita Mathur, PhD
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 6, 2012
First Posted
July 11, 2012
Study Start
July 1, 2012
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
February 9, 2016
Record last verified: 2015-05